ToplineShares of Swiss pharma giant Roche climbed Wednesday after it reported promising results for an experimental weight loss pill, part of a cohort of hopeful competitors racing to challenge Novo Nordisk and Eli Lilly in the burgeoning diabetes and obesity drug market amid growing evidence the drugs can treat many other health conditions like kidney disease and sleep apnea.Roche said it had promising results from an ongoing trial for its obesity pill and would progress to ... [+] mid-stage trials.SOPA Im ...